Denis S Fedorinov

13PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 26, 2026
Allelic Variants of the DPYD Gene in Russian Patients with Cancer: The Results of Exome Sequencing.

|Sep 24, 2026
Impact of Cytochrome P450 and P-glycoprotein Gene Polymorphisms on the Risk of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban.

|May 13, 2026
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.

|Nov 27, 2025
Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort.

Denis Fedorinov, Vladimir Lyadov, Marina Lyadova

|Aug 10, 2024
MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy.

Anna Ikonnikova, Denis Fedorinov, Dmitry Gryadunov

|Sep 13, 2022
Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines.

Denis S Fedorinov, Vladimir K Lyadov, Dmitriy A Sychev

Pageof 3

Frequent Collaborators

5 joint publications

Sherzod P Abdullaev

5 joint publications

Dmitry Sychev

4 joint publications

Vladimir Lyadov

2 joint publications

Anastasia Kachanova